Cellectar Biosciences ROA 2006-2018 | CLRB

Current and historical return on assets (ROA) values for Cellectar Biosciences (CLRB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Cellectar Biosciences ROA for the three months ending September 30, 2018 was -140.75%.
Cellectar Biosciences ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.02B $0.02B -136.00%
2018-06-30 $-0.02B $0.01B -150.00%
2018-03-31 $-0.02B $0.01B -130.43%
2017-12-31 $-0.02B $0.01B -117.65%
2017-09-30 $-0.02B $0.01B -113.21%
2017-06-30 $-0.01B $0.01B -107.69%
2017-03-31 $-0.01B $0.02B -104.00%
2016-12-31 $-0.01B $0.02B -87.80%
2016-09-30 $-0.00B $0.01B -23.53%
2016-06-30 $-0.00B $0.01B -25.81%
2016-03-31 $-0.00B $0.01B -27.59%
2015-12-31 $-0.01B $0.01B -58.82%
2015-09-30 $-0.01B $0.01B -92.31%
2015-06-30 $-0.01B $0.01B -57.14%
2015-03-31 $-0.01B $0.01B -60.87%
2014-12-31 $-0.01B $0.01B -74.42%
2014-09-30 $-0.01B $0.02B -97.30%
2014-06-30 $-0.01B $0.01B -129.03%
2014-03-31 $-0.01B $0.01B -108.11%
2013-12-31 $-0.01B $0.01B -93.02%
2013-09-30 $-0.01B $0.01B -68.09%
2013-06-30 $-0.01B $0.01B -85.11%
2013-03-31 $-0.01B $0.01B -85.11%
2012-12-31 $-0.01B $0.01B -85.71%
2012-09-30 $-0.01B $0.01B -85.71%
2012-06-30 $-0.01B $0.01B -82.05%
2012-03-31 $-0.01B $0.01B -102.86%
2011-12-31 $-0.01B $0.01B -118.52%
2011-09-30 $-0.01B $0.01B -114.29%
2011-06-30 $-0.01B $0.01B -117.65%
2011-03-31 $-0.00B $0.00B -123.08%
2010-12-31 $0.00B $0.01B 44.44%
2010-09-30 $-0.01B $0.00B -200.00%
2010-06-30 $-0.01B $0.00B -208.00%
2010-03-31 $-0.02B $0.01B -246.15%
2009-12-31 $-0.02B $0.01B -340.74%
2009-09-30 $-0.01B $0.01B -252.63%
2009-06-30 $-0.01B $0.01B -282.35%
2009-03-31 $-0.01B $0.01B -266.67%
2008-12-31 $-0.02B $0.00B -377.78%
2008-09-30 $-0.02B $0.00B -314.29%
2008-06-30 $-0.03B $0.01B -250.00%
2008-03-31 $-0.02B $0.01B -174.55%
2007-12-31 $-0.02B $0.01B -131.03%
2007-09-30 $-0.02B $0.02B -101.69%
2007-06-30 $-0.01B $0.02B -84.21%
2007-03-31 $-0.01B $0.01B -67.92%
2006-12-31 $-0.01B $0.01B -52.46%
2006-09-30 $-0.01B $0.01B -44.44%
2006-06-30 $-0.00B $0.02B -34.78%
2006-03-31 $-0.00B $0.02B -51.61%
2005-12-31 $-0.00B $0.01B -92.31%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.011B $0.000B
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $124.396B 19.07
Abbott Laboratories (ABT) United States $121.907B 24.70
Stryker (SYK) United States $62.115B 23.41
Boston Scientific (BSX) United States $50.107B 25.32
Baxter (BAX) United States $33.967B 21.93
Zimmer Biomet Holdings (ZBH) United States $22.913B 14.86
Smith & Nephew SNATS (SNN) United Kingdom $16.016B 0.00
ResMed (RMD) United States $14.484B 27.62
Perrigo (PRGO) Ireland $8.621B 13.09
Bio-Rad Laboratories (BIO) United States $8.038B 51.40
Canopy Growth (CGC) Canada $7.963B 0.00
Hill-Rom Holdings (HRC) United States $6.061B 19.22
Aurora Cannabis (ACB) Canada $5.941B 32.42
Haemonetics (HAE) United States $5.495B 48.32
Hutchison China MediTech (HCM) China $5.011B 0.00
Insulet (PODD) United States $4.690B 0.00
ICU Medical (ICUI) United States $4.600B 25.63
GW Pharmaceuticals (GWPH) United Kingdom $3.898B 0.00
Agios Pharmaceuticals (AGIO) United States $3.709B 0.00
National Vision Holdings (EYE) United States $3.224B 62.36
Neogen (NEOG) United States $3.190B 48.31
NuVasive (NUVA) United States $3.045B 28.33
Quidel (QDEL) United States $2.390B 31.16
Aphria (APHA) $2.383B 0.00
NxStage Medical (NXTM) United States $1.935B 0.00
Phibro Animal Health (PAHC) United States $1.455B 20.60
AtriCure (ATRC) United States $1.189B 0.00
Cardiovascular Systems (CSII) United States $1.007B 1450.50
VAREX IMAGING (VREX) United States $0.933B 18.74
Meridian Bioscience (VIVO) United States $0.816B 26.01
Surmodics (SRDX) United States $0.775B 118.39
OraSure Technologies (OSUR) United States $0.771B 43.38
Eagle Pharmaceuticals (EGRX) United States $0.738B 23.67
PetIQ (PETQ) United States $0.737B 20.93
MacroGenics (MGNX) United States $0.702B 0.00
Cerus (CERS) United States $0.685B 0.00
Lantheus Holdings (LNTH) United States $0.604B 18.68
Omeros (OMER) United States $0.569B 0.00
Owens & Minor (OMI) United States $0.550B 6.22
Insys Therapeutics (INSY) United States $0.531B 0.00
LeMaitre Vascular (LMAT) United States $0.510B 25.05
NanoString Technologies (NSTG) United States $0.478B 0.00
TG Therapeutics (TGTX) United States $0.429B 0.00
Evolus (EOLS) United States $0.373B 0.00
Quanterix (QTRX) United States $0.361B 0.00
Utah Medical Products (UTMD) United States $0.326B 21.11
Cytosorbents (CTSO) United States $0.287B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.254B 0.00
Rockwell Medical (RMTI) United States $0.230B 0.00
Surface Oncology (SURF) United States $0.218B 0.00
BioLife Solutions (BLFS) United States $0.197B 265.75
Bovie Medical (BVX) United States $0.189B 0.00
Chimerix (CMRX) United States $0.168B 0.00
Fonar (FONR) United States $0.141B 7.07
Conatus Pharmaceuticals (CNAT) United States $0.138B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.107B 0.00
Chembio Diagnostics (CEMI) United States $0.099B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 21.53
InfuSystems Holdings (INFU) United States $0.067B 0.00
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.047B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Myomo (MYO) United States $0.024B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Valeritas Holdings (VLRX) United States $0.017B 0.00
Senestech (SNES) United States $0.017B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00